Ticker Launch
Sign inTry it free

SPAC · Merger completed

Big Rock Partners Acquisition Corp.

Business combination with NeuroRx, Inc.

Big Rock Partners Acquisition Corp. is a blank-check company (SPAC) that raised $60M in its initial public offering on Nov 21, 2017, listing on Nasdaq Capital Market. It completed its business combination with NeuroRx, Inc. on May 24, 2021; the combined company is NRX Pharmaceuticals, Inc. (NRXP). Officer of Atlantic Gulf Communities led the IPO, with Homart Development Company. Akerman advised the SPAC and Graubard Miller advised the underwriters on the IPO.

NeuroRx is a pharmaceutical company developing RLF-100 and NRX-101. NRX-101 has Breakthrough Therapy Designation and a Special Protocol Agreement for suicidal bipolar depression and is in Phase 3 trials.

Status
Merger completed
IPO date
Nov 21, 2017
IPO size
$60M
IPO exchange
Nasdaq Capital Market
Target
NeuroRx, Inc.
Announced
Dec 17, 2020
Closed
May 24, 2021
Combined company
NRX Pharmaceuticals, Inc. (NRXP)
IPO underwriters
Officer of Atlantic Gulf Communities and Homart Development Company
SPAC counsel (IPO)
Akerman
Underwriters' counsel (IPO)
Graubard Miller

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021